Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Y. H. Andrew Wu"'
Autor:
Akio Saiura, Yoshihiro Ono, Hiromichi Ito, Yu Takahashi, Y. H. Andrew Wu, Atsushi Oba, Yosuke Inoue, Takafumi Sato, T. Kato
Publikováno v:
J Gastrointest Oncol
The improvement of effective multidrug agents has allowed more patients to undergo resection for pancreatic cancer (PC). In the conversion cases of initially unresectable PC after induction chemotherapy, pancreatic surgeons often encounter challengin
Publikováno v:
The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases ISBN: 9789811900624
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::483eaa8c1788bd2db48d1a24f918d75e
https://doi.org/10.1007/978-981-19-0063-1_40
https://doi.org/10.1007/978-981-19-0063-1_40
Publikováno v:
British Journal of Surgery. 110:112-112
Autor:
Y. H. Andrew Wu, Otoniel Riverol, K. X. Alvin Lee, Kai-Hua Chang, Ben Harnke, Li-Ying Liao, Hung-Chi Chen
Publikováno v:
Journal of plastic, reconstructiveaesthetic surgery : JPRAS. 76
Due to the rarity of the need for claviculectomy and the subsequent clavicle reconstruction, currently there is no consensus on the reconstructive approach for the clavicle. The clavicle is an essential bony structure that is necessary for optimal up
Publikováno v:
Textbook of Pancreatic Cancer ISBN: 9783030537852
Vein resection and reconstruction have become a common approach for the treatment of pancreatic ductal adenocarcinoma (PDAC) and are listed in multiple major guidelines. However, the need of performing large artery resection and reconstruction in tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::822c5d02babf3ceb96662c871c43a401
https://doi.org/10.1007/978-3-030-53786-9_56
https://doi.org/10.1007/978-3-030-53786-9_56
Autor:
Richard D. Schulick, Ronggui Lin, Cheryl Meguid, Atsushi Oba, Marco Del Chiaro, Y. H. Andrew Wu, Shuichi Watanabe
Publikováno v:
J Gastrointest Oncol
Pancreatic cancer (PC) is likely to become the second leading cause of malignancy-associated mortality within the next 10 years and surgery remains the best hope for cure. The introduction of effective neoadjuvant treatment (NAT) has increased the re
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.